rs886039106
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_003242.6(TGFBR2):c.1178G>A(p.Cys393Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_003242.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFBR2 | ENST00000295754.10 | c.1178G>A | p.Cys393Tyr | missense_variant | Exon 4 of 7 | 1 | NM_003242.6 | ENSP00000295754.5 | ||
TGFBR2 | ENST00000359013.4 | c.1253G>A | p.Cys418Tyr | missense_variant | Exon 5 of 8 | 1 | ENSP00000351905.4 | |||
TGFBR2 | ENST00000672866.1 | n.2774G>A | non_coding_transcript_exon_variant | Exon 4 of 7 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:2
This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 393 of the TGFBR2 protein (p.Cys393Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with TGFBR2-related conditions (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 264260). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TGFBR2 protein function. For these reasons, this variant has been classified as Pathogenic. -
The p.C393Y pathogenic mutation (also known as c.1178G>A), located in coding exon 4 of the TGFBR2 gene, results from a G to A substitution at nucleotide position 1178. The cysteine at codon 393 is replaced by tyrosine, an amino acid with highly dissimilar properties, and is located in a protein kinase domain. This alteration was confirmed as de novo in a proband whose clinical presentation is consistent with Loeys-Dietz syndrome (LDS). Another alteration at the same codon, p.C393G (c.1177T>G), has been observed in an individual with LDS (Frischmeyer-Guerrerio PA et al. Sci Transl Med 2013; 5(195):195ra94) and in a thoracic aortic disease cohort (Jondeau G et al. Circ Cardiovasc Genet, 2016 Dec;9:548-558); however, clinical details were limited. Based on the supporting evidence, p.C393Y is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at